The role of uric acid in mineral bone disorders in chronic kidney disease
- 27 April 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 32 (5) , 709-717
Abstract
Increasing survival in the chronic kidney disease (CKD) population exposes the bone to the cumulative detrimental sequelae of CKD, now defined physiologically and histopathologically as chronic kidney disease mineral bone disorder (CKD-BMD). This disorder is increasingly recognized as a “nontraditional” driver of morbidity and mortality and presents an opportunity to improve CKD outcomes via research. However, recent advances in the literature on this topic have not yet been collected into a single review. Therefore, this report aims to discuss the disordered renal-bone axis in CKD-BMD, molecular and hormonal drivers, novel treatment strategies, and forthcoming research in a clinician-directed format. A key novel topic will be the unique impact of uric acid on CKD-BMD, which is poised to apply extensive existing research in the uric acid domain to benefit the CKD-BMD population.Keywords
This publication has 101 references indexed in Scilit:
- Association between Vitamin D Insufficiency and Elevated Serum Uric Acid among Middle-Aged and Elderly Chinese Han WomenPLOS ONE, 2013
- The independent association between parathyroid hormone levels and hyperuricemia: a national population studyArthritis Research & Therapy, 2012
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Uric Acid and Pentraxin-3 Levels Are Independently Associated with Coronary Artery Disease Risk in Patients with Stage 2 and 3 Kidney DiseaseAmerican Journal of Nephrology, 2011
- Serum Uric Acid Level and Endothelial Dysfunction in Patients with Nondiabetic Chronic Kidney DiseaseAmerican Journal of Nephrology, 2011
- Serum uric acid is associated with bone health in older men: A cross-sectional population-based studyJournal of Bone and Mineral Research, 2010
- FGF-23: More than a regulator of renal phosphate handling?Journal of Bone and Mineral Research, 2010
- Vascular calcification in chronic kidney diseaseClinical Science, 2010
- Oxidative stress in bone remodelling and diseaseTrends in Molecular Medicine, 2009
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the communityAtherosclerosis, 2009